Amgen's GLP-1 Obesity Drug Development Progress Discussed | Retatrutide News

Amgen's head of obesity research discussed their experimental GLP-1 drug, highlighting ongoing development. This reflects a competitive landscape in GLP...
Market News · October 27, 2026